BioInform GenomeWeb News Premium Content Existing subscribers login here. New to BioInform? For a trial subscription click here.

Genostar Expands Deal with Biopharma Merial
To Help Hunt Pathogenic Virulence Factors

[May 9, 2008]

By Vivien Marx

As part of an expanded deal, Genostar will provide an update to its Iogma software so that Merial, a Sanofi-Aventis/Merck joint venture, can accelerate its search for vaccines and treatments of bacterial infections in livestock and companion animals.

Login | Subscribe